Direct current shock and antidysrhythmic drugs

Area of Science:

• Cardiology
• Clinical Electrophysiology

Background:

• Atrial fibrillation (AF) is a common arrhythmia requiring treatment.
• Direct current (DC) shock is a primary method for AF cardioversion.
• The role of antiarrhythmic drugs in conjunction with DC shock requires further investigation.

Purpose of the Study:

• To evaluate the efficacy and safety of combining antiarrhythmic drugs with DC shock for AF treatment.
• To compare the effectiveness of DC shock alone versus combined therapy.
• To assess the impact of specific drug combinations on DC shock outcomes.

Main Methods:

• Review of 457 AF episodes in 318 patients treated with DC shock.
• Concomitant use of antiarrhythmic drugs (quinidine, procainamide, propranolol) in 389 instances.
• Animal experiments studying combined quinidine/procainamide and DC shock effects.

Main Results:

• Combined drug and DC shock therapy yielded higher conversion rates than DC shock alone.
• Procainamide and propranolol combination showed a statistically significant improvement (p<0.01).
• Antiarrhythmic drugs did not generally reduce DC shock-induced dysrhythmias, but propranolol/procainamide pretreatment lessened certain digitalis/DC shock-induced arrhythmias (p<0.01).

Conclusions:

• Combined antiarrhythmic drug and DC shock therapy enhances AF cardioversion.
• Caution is necessary due to potential enhanced cardiotoxicity and drug-related post-shock rhythm disorders.
• Specific drug combinations may mitigate certain adverse events, but overall safety requires careful consideration.